Genome British Columbia

What Genome British Columbia does

Genome British Columbia (Genome BC) is a non-profit, government-funded research organization founded in 2000 and headquartered in Vancouver. It functions as the regional genomics funding arm of Genome Canada, administering competitive grant programs and direct investments that translate laboratory genomics research into commercial and societal applications within British Columbia.

Its core offerings are two funding programs. The Genomic Applications Partnership Program (GAPP) is a flagship commercialization initiative co-run with Genome Canada, offering up to $3 million per project (National GAPP: up to $2M from Genome Canada plus up to $1M from Genome BC; Regional GAPP for earlier-stage projects typically $300K–$1M+). The Industry Innovation Fund deploys growth capital into BC-based startups, including recent investments of $1.75M in Maia Farms (mushroom mycelium protein) and $1.5M in Verdi (AI-driven agritech software). Beyond these programs, Genome BC funds research collaborations spanning crop genomics, marine/fisheries genomics, chronic wound therapeutics, HIV transmission modeling, and biomining.

The business model is grant administration and funding intermediation rather than product sales. Genome BC draws capital from federal and provincial sources (Genome Canada, CIHR, Canadian Cancer Society) and re-deploys it via competitive calls and strategic partnerships with universities (UBC), federal agencies (Agriculture and Agri-Food Canada), health authorities (Vancouver Coastal Health), industry (Rio Tinto, Summerland Varieties), and international research institutions (Institut Pasteur, Université Paris Cité). Customer concentration is low given the breadth of funded recipients across multiple verticals.

Name

Genome British Columbia

Legal name

Genome British Columbia

Website

https://genomebc.ca

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Genomics Research Funding

NAICS

Grantmaking and Giving Services (81321), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Research & Science Grantmaking Foundations (BPAGAKAI)

akta.pro secondary industries

Health & Medical Research Grantmaking Foundations (BPAGAKAL), Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB), Transcriptomics & Gene Expression Profiling Services (HLAGANAE), Research Administration & Grants Management Support (Pre/Post-Award, Compliance) (EDAEALAO)

Keywords

• Genomics research funding
• Life sciences grants
• Biotech commercialization
• Agricultural genomics
• Health genomics programs

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Others

Distribution channels1 record

Marketing channels3 records

Core offering

Genome British Columbia operates as a non-profit research funding organization that distributes grants and co-investments to support genomics-driven research and commercialization in British Columbia. Its core offerings are the Genomic Applications Partnership Program (GAPP), which funds academic-industry collaborations with up to $3 million, and the Industry Innovation Fund, which provides growth capital to local startups in the agritech and biotech sectors.

Product overview

Genome British Columbia operates as a provincial funding and research organization rather than a product company. Its offerings consist of two main funding programs: the Genomic Applications Partnership Program (GAPP), which supports commercialization of genomics innovations through academic-industry collaborations with funding up to $3 million, and the Industry Innovation Fund, which provides growth capital to local agritech startups. The organization also funds various research initiatives in health, agriculture, mining, and environmental genomics.

Differentiator

Problem solved

Functional benefit

Brands

• GAPP (Genomic Applications Partnership Program): Flagship commercialization funding initiative delivered in partnership with Genome Canada, supporting collaborations between Canadian for-profit companies and academic researchers to advance genomics-driven innovation.

Products and services

• Genomic Applications Partnership Program (GAPP) A flagship commercialization funding initiative delivered in partnership with Genome Canada, supporting collaborations between Canadian for-profit companies and academic researchers to advance genomics-driven innovation. Offers National GAPP (up to $3 million total) and Regional GAPP (typically $300,000 to over $1 million).
• Industry Innovation Fund Provides growth capital to British Columbian startups in the agritech and biotech sectors, funding scale-up of genomics-based innovations such as mushroom mycelium protein production and AI-driven agricultural software.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Partnerships

Eleven partnerships are on record, tiered flagship, core and minor.

• University of British Columbia - Bradshaw Research Institute for Minerals and MiningflagshipStrategic or Co-development Partner · 27 April 2026Joint investment of up to $1 million over three years to translate laboratory biomining research into commercial-scale mining applications. Initiative focuses on using microorganisms to extract metals from ores and tailings.
• Rio Tinto - Rio Tinto Centre for Future MaterialscoreStrategic or Co-development Partner · 27 April 2026Provides researchers access to active mine sites and pathway from laboratory proof-of-concept to industry implementation for biomining research. Partnership positions Canada to extract more value from existing mining operations and critical mineral byproducts.
• Genome CanadaflagshipStrategic or Co-development Partner · 29 March 2026Flagship commercialization funding initiative delivered in partnership with Genome Canada. Supports collaborations between Canadian for-profit companies and academic researchers to advance genomics-driven innovation.
• Institut PasteurcoreStrategic or Co-development Partner · 5 March 2026International research partner on UPFront project studying ultra-processed foods and colorectal cancer risk, along with Université Paris Cité.
• Université Paris CitécoreStrategic or Co-development Partner · 5 March 2026International research partner on UPFront project studying ultra-processed foods and colorectal cancer risk.
• Agriculture and Agri-Food CanadacoreStrategic or Co-development Partner · 26 February 2026Collaboration to use genomics to accelerate cherry breeding, potentially shortening the traditional 30-year cultivation timeline and developing varieties suited to temperature extremes.
• Summerland VarietiescoreStrategic or Co-development Partner · 26 February 2026Partnership to apply genomic data to cherry breeding, aiming to help BC growers develop climate-ready crops and reduce reliance on international seed suppliers.
• University of British ColumbiacoreStrategic or Co-development Partner · 26 February 2026Led research to identify genetic markers in wild and traditional carrot varieties to develop seeds suitable for BC's organic growing conditions and climate.
• SeedChangeminorStrategic or Co-development Partner · 26 February 2026Collaboration to identify genetic markers in carrot varieties for BC organic growing conditions.
• Dr. Jeffrey Joy (Researcher)coreStrategic or Co-development Partner · 1 December 2025Led project using advanced genomic, AI, and machine learning tools to better understand HIV transmission patterns in British Columbia and improve prevention strategies.
• Vancouver Coastal HealthcoreStrategic or Co-development Partner · 17 November 2025Collaboration to develop a plant-based gel to improve healing of chronic wounds (bed sores) using compounds approved by Health Canada.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Genome Canada: Genome Canada is the federal parent organization that funds Genome BC and other regional genome centers. It is directly comparable as the apex genomics research funding body in Canada, sharing mission, governance model, and program design with Genome BC at a national scale.
• Canadian Institutes of Health Research (CIHR): CIHR is a major federal health research funding agency in Canada that co-funds some Genome BC-supported projects. It is comparable as a large-scale Canadian health and biomedical research funder, though operating at a national and broader scope than Genome BC.
• Natural Sciences and Engineering Research Council of Canada (NSERC): NSERC is a federal research funding agency that supports natural sciences and engineering research in Canada. Genome BC's agritech, mining, and environmental genomics funding areas overlap with NSERC's mandate, making it a comparable research funding intermediary.

Direct peers

• Génome Québec: Génome Québec is a sibling regional genome center serving Quebec with the same funding intermediary model, partnership with Genome Canada, and focus on genomics research commercialization. It is the most direct functional peer of Genome BC.
• Ontario Genomics: Ontario Genomics is another regional Genome Canada-funded center serving Ontario with a comparable model of funding genomics research, industry partnerships, and commercialization support — directly comparable in mandate and operating structure to Genome BC.
• Genome Alberta: Genome Alberta is a regional genomics funding organization serving Alberta with similar Genome Canada partnership, grantmaking programs, and industry-academia collaboration focus — a direct peer in the national genomics funding network.
• Genome Atlantic: Genome Atlantic is the regional Genome Canada center serving Atlantic Canada, with the same model of genomics research funding and commercialization support. It is a direct peer to Genome BC within the national Genome Canada network.

Emerging players

• Mitacs: Mitacs is a Canadian not-for-profit research funding organization that connects academia with industry through funding programs. While not focused exclusively on genomics, it operates a comparable funding intermediary model and serves overlapping researcher populations in BC.

Regional players

• Alberta Innovates: Alberta Innovates is a provincial research and innovation funding organization that, like Genome BC, funds applied research with commercialization pathways. It operates in a different province and broader mandate but shares the model of province-level research funding intermediation.

Others

• Prairie Diagnostic Services: Prairie Diagnostic Services is a Western Canadian laboratory services organization adjacent to the genomics and life sciences ecosystem that Genome BC supports. It represents an ecosystem participant rather than a direct competitor, sharing geographic and sectoral context.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/genomebc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments18 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genome British Columbia